AGP Executive Report
Last update: 2 hours agoKenya Cannabis Court Ruling: Kenya’s High Court rejected Rastafarians’ bid to use marijuana as a religious sacrament, saying they failed to prove it’s “necessary” to their practice, though the judge urged a wider national debate as the current law may be “untenable.” Medical Cannabis Research: A new study finds more U.S. teens seeking treatment for cannabis use disorder are facing longer delays getting care, even as overall teen cannabis use levels off. Industry Expansion: Greenlight hit Ohio’s legal dispensary cap with four new locations plus in-state manufacturing, while Curaleaf opened a new Florida dispensary in Edgewater, growing its Florida footprint to 74. Cannabis 2.0 Moves: TobaGrown acquired Manitoba extract brands HWY 59 and Banter to expand into extracts and offer extraction services locally. Business & Culture: RAW Rolling Papers bought RAW Genetics IP to expand into cannabis genetics and seeds, and Glass House updated its at-the-market equity program after NYSE listing. Clinical Trial Update: SciSparc’s NeuroThera started a Phase IIb trial site in Germany for its cannabinoid-based Tourette’s treatment.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.